An ongoing multicenter randomized trial is testing the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) protocol for postpartum depression. Thalia Robakis, MD, PhD, of the Icahn School of Medicine at Mount Sinai described the study, which is enrolling patients across four sites: New York, UMass, UT Austin, and the Medical University of South Carolina.
The trial is still enrolling and no results have been reported. Robakis said SAINT's compressed one-week course may suit new mothers, for whom rapid symptom resolution matters for both infant health and family functioning, and that a nonpharmacological approach may appeal to postpartum women who prefer to avoid medication, especially if breastfeeding.
SAINT differs from conventional TMS by compressing multiple daily sessions into about a week, using neuroimaging-based individualized targeting, and delivering a substantially higher total pulse count.
Whether SAINT is effective and well tolerated for postpartum depression is what the trial is designed to test. Psychiatric Times published the article on April 30, 2026.
Source
Reporting based on coverage from Psychiatric Times. This article is editorial summary intended for general information; it is not medical advice.
